Haemodynamic effects of dihydroergotamine in patients with postural hypotension.
D000284:Administration, Oral; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects*; D002302:Cardiac Output / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D004879:Ergotamines; D005260:Female; D005542:Forearm / Q000098:blood supply; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy*; D007275:Injections, Intravenous; D008297:Male; D012039:Regional Blood Flow; D013268:Stimulation, Chemical; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects
D004879:Ergotamines; D004087:Dihydroergotamine